Biocept (BIOC) tanked today: expect recovery?

6:40 pm ET, 14 Aug 2018

Biocept, Inc. (BIOC) shares are trading at 3.39, down -13% in the after-hours.  The company missed its earnings forecast, causing a pretty steep sell-off.  

 What's BIOC stock price forecast?  Will the price of BIOC shares recover?

First, here are the facts.  Biocept Q2 results include revenues of $0.8M (down -38%) and a net loss of -$5.7M.  The net loss per share amounted to $(6.32).  The revenue drop was influenced by the transition from cash-based revenue recognition to accrual.  Revenues were down 25% year-on-year on an accrual basis.

The company is now in the cost-cutting mode.  A cost reduction initiative underway aims at saving as much as $1.5M per annum.  By completing shareholder rights offering, the company added $10M to the balance sheet and reduced long-term debt. 

The goal of the transformation underway is to transition from reference lab services to diagnostic kit manufacturing.  Commercially, the company is making progress: it's validating its liquid biopsy sequencing gene panel in collaboration with Thermo Fisher Scientific--and results will be reported later this year.  

What is the sentiment towards the BIOC stock? Our technical analysis shows that: 

  • The stock short-term sentiment (next 30 days) is trending negative;
  • The mid-term sentiment (3-6 months) is trending positive;
  • The long-term sentiment (9-12 months) is trending negative. 

Biocept, Inc. (BIOC) short share of float is 9.04%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock.

Biocept (BIOC) average analyst price target ($0.83) is -80.79% below its current price ($4.32).

For the latest price and information on Biocept, Inc., please visit Finstead and search for "BIOC price" or "BIOC news".

Biocept, Inc. (BIOC) Stock Guide

Updated at: 7:37 pm ET, 16 Sep 2020

Before we start: if you're looking for BIOC stock price, you can quickly find it out by visiting Finny and typing "BIOC quote". If you're looking for a quick scoop on BIOC stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "BIOC". You'll get all this info in one place. Or you can just type "BIOC news" to get the latest stock news.

Looking to buy or sell Biocept, Inc. (BIOC)? Interested in getting the full scoop on BIOC, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this BIOC stock guide, we'll address key questions about BIOC, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. BIOC buy or sell? What is BIOC Finny Score?
2. What are the reasons to buy BIOC? Why should I buy BIOC stock?
3. What are the reasons to sell BIOC? Why should I sell BIOC stock?
4. What are BIOC key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Analysis

1. BIOC buy or sell? What is BIOC Finny Score?

#{finnyScore:null}Our quantitative analysis shows 0 reasons to buy and 2 reasons to sell BIOC. BIOC doesn’t have an assigned Finny Score, because we don’t have sufficient data points to score the stock.

2. What are the reasons to buy BIOC? Why should I buy BIOC stock?

We can’t think of any good reason to buy this stock, which doesn’t mean they don’t exist.

3. What are the reasons to sell BIOC? Why should I sell BIOC stock?

Let's look at the reasons to sell BIOC stock (i.e., the bear case):

  • BIOC stock price ($4.69) is at the 52-week high. Perhaps now is a good time to sell? See BIOC price chart.
  • BIOC profitability is declining. The YoY profit margin change was -349.14 percentage points. See BIOC profitability chart.

Key Stats

4. What are BIOC key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for BIOC:

Metrics BIOC
Price $4.23
Average Price Target / Upside N/A
Average Analyst Rating N/A
Forward Dividend Yield 0.00%
Industry Diagnostics & Research
Sector Healthcare
Number of Employees 95
Market Cap $00
Forward P/E Ratio N/A
Price/Book Ratio N/A
Revenue (TTM) N/A
YoY Quarterly Revenue Growth N/A
Profit Margin N/A

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us